The author analyzes how unemployment insurance (UI) affects on-the-job search among older workers in the United States, allowing for job insecurity.
Aug 16, 2016
Reverting to Informality: Unregistered Property Transactions and the Erosion of the Titling Reform in Peru
Exploits a natural experiment provided by the elimination of a registration system targeted to the poor in Peru to identify the effects of increasing the costs and complexity of registering property transactions in urban areas.
Jul 28, 2016
Evaluation of a Female Sterilization Campaign in Peru: An Application of Propensity Score Reweighting Methods with Unobserved Participation Status
Evaluates the impact of a female sterilization campaign in Peru in the 1990s using a propensity score reweighting method that accounts for a contaminated treatment group problem.
Nov 17, 2015
The Socioeconomic Effects of the Working Poor Moving to Permanent Dwellings: The Case of the Ashray Affordable Housing Pilot Project in India
RAND Corporation researchers assessed whether low-cost housing projects may help low-income workers and their families improve their living conditions while still allowing developers to recover their costs.
May 30, 2014
The Supplemental Nutrition Assistance Program and Material Hardships Among Low-Income Households with Children
This study estimates the effects of participation in the Supplemental Nutrition Assistance Program (SNAP) on the risk of food as well as nonfood material hardships experienced by low-income households with children.
Dec 1, 2013
Describes pharmaceutical regulations in nineteen developed countries from 1992 to 2004 and analyzes how different regulations affect pharmaceutical revenues.
Jan 9, 2009
Investigates the effects on consumers of lowering U.S. pharmaceutical prices under various assumptions and finds that publicly financing price reductions, without affecting manufacturer prices, delivers benefits in virtually all plausible cases.
Jan 9, 2009
Discusses the effects of regulating drug prices in the United States in terms of the trade-off between benefiting the current generation (with lower prices) and benefiting future generations (with greater pharmaceutical innovation).
Dec 11, 2008